Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 18,794 | 14,481 | 16,348 | 13,933 | 12,691 |
| Cost of Goods | 381 | 572 | 442 | 929 | 685 |
| Gross Profit | 18,413 | 13,909 | 15,906 | 13,004 | 12,006 |
| Operating Expenses | 26,108 | 27,589 | 35,907 | 38,151 | 34,499 |
| Operating Income | -7,314 | -13,108 | -19,559 | -24,218 | -21,808 |
| Interest Expense | 3,467 | 3,624 | 3,640 | 3,876 | 3,797 |
| Other Income | 215 | 84 | 124 | 512 | 734 |
| Pre-tax Income | -10,566 | -16,648 | -23,075 | -27,582 | -24,871 |
| Net Income Continuous | -10,566 | -16,648 | -23,075 | -27,582 | -24,871 |
| Net Income | $-10,566 | $-16,648 | $-23,075 | $-27,582 | $-24,871 |
| EPS Basic Total Ops | -0.37 | -0.59 | -0.83 | -0.99 | -0.90 |
| EPS Basic Continuous Ops | -0.37 | -0.59 | -0.83 | -0.99 | -0.90 |
| EPS Diluted Total Ops | -0.37 | -0.59 | -0.83 | -0.99 | -0.90 |
| EPS Diluted Continuous Ops | -0.37 | -0.59 | -0.83 | -0.99 | -0.90 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.59 | -0.83 | N/A | N/A |
| EBITDA(a) | $-7,130 | $-12,979 | $-20,522 | $-23,952 | $-21,484 |